President Donald Trump's top health official Monday blasted Pfizer's new drug price hikes, calling the increases a "tipping point" that will lead to policy changes, the Washington Examiner reported.
Health and Human Services Secretary Alex Azar pointed to a Trump tweet Monday that blasted Pfizer and other unnamed drug companies for hiking drug prices "for no reason."
Trump on May 30 had predicted major drug companies would voluntarily slash prices on their products in a matter of weeks.
"The drug companies that recently increased prices will be remembered for creating a tipping point in U.S. drug pricing policy," Azar said, the Examiner reported, saying the "American people have noticed."
"Change is coming to prescription drug pricing, whether it's painful or not for pharmaceutical companies," Azar said at the 340B Coalition summer meeting in Washington, the Examiner reported.
The coalition is a group of hospitals and providers that support the drug discount program called 340B.
He added the administration hopes to restore transparency.
"Most significantly, we are examining whether we need to disrupt the entire system of rebates, which drives list prices ever higher while patients keep paying more," he said. "Eliminating rebates within the Medicare program, pushing the system toward fixed-price discounts, is well within our administrative powers."
© 2021 Newsmax. All rights reserved.